Pricing Log in Create free account

ACADIA Pharmaceuticals Inc. (ACAD) vs Telix Pharmaceuticals Limited (TLX)

ACADIA Pharmaceuticals Inc. and Telix Pharmaceuticals Limited are both Biotechnology companies. ACADIA Pharmaceuticals Inc. and Telix Pharmaceuticals Limited are of similar size ($3.6B and $3.4B). Across the 9 metrics below, ACADIA Pharmaceuticals Inc. leads on 8 and Telix Pharmaceuticals Limited on 1.

Valuation

Metric ACAD TLX Biotechnology median
P/E 8.50 — 8.50
P/S 2.88 — 9.71
P/B 2.51 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 24.19 n/m 0.64
EV/Sales 2.04 n/m 9.21
Earnings yield 11.77% — (33.15%)
Free cash flow yield (1.59%) 0.00% (25.50%)

Profitability

Metric ACAD TLX Biotechnology median
Gross margin 91.13% — 65.16%
Operating margin 7.59% — 0.00%
Net margin 33.42% — 0.00%
Free cash flow margin 12.79% 0.00% 0.00%
Return on equity 35.74% 0.00% (56.36%)
Return on assets 25.64% 0.00% (48.04%)
Return on invested capital 15.42% 0.00% 0.00%

Growth

Metric ACAD TLX Biotechnology median
Revenue growth (TTM) 11.75% — 6.02%
EPS growth (last fiscal year) 69.12% (120.00%) 30.26%
Revenue growth, 5-year CAGR 19.39% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ACAD TLX Biotechnology median
Debt to equity 0.00 1.18 0.00
Current ratio 3.39 2.01 4.72
Net debt to EBITDA (7.37) 6.25 0.96

Dividend

Metric ACAD TLX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ACAD TLX Biotechnology median
Market cap 3.40b 3.60b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack